Pearl BioSystem utilizes a microgravity environment to screen chemical libraries in liquid pearls, cultivating spheroids that closely mimic in vivo conditions for drug discovery and toxicology testing. This method addresses the challenge of achieving controlled, large-scale production of spheroids, enhancing the reliability of cellular studies.
Funding
Funding not disclosed
Founders
Product
Problem
Producing spheroids, three-dimensional cellular aggregates that mimic in vivo environments, in a controlled and scalable manner remains a significant challenge. Existing techniques often struggle to create conditions that promote differentiation, viability, and cell-cell attachment, which are critical for self-assembly.
Solution
Pearl BioSystem utilizes a microgravity environment to screen chemical libraries within liquid pearls, enabling the cultivation of spheroids that closely mimic in vivo conditions. This approach facilitates efficient spheroid formation, addressing the limitations of traditional methods. By leveraging microgravity, the platform promotes natural cell clustering and spheroid development, offering a potential solution for large-scale spheroid production. The technology aims to enhance the reliability and reproducibility of cellular studies for drug discovery and toxicology testing.
Target Audience
The primary audience includes researchers and pharmaceutical companies involved in drug discovery, toxicology testing, and tissue engineering who require reliable and scalable methods for producing spheroids.
Features
- Spheroid formation in a microgravity environment.
- Chemical library screening within liquid pearls.
- Enhanced cell differentiation, viability, and cell-cell attachment.
- Scalable spheroid production.
- Mimicking of in vivo conditions for cellular studies.